Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Adalimumab 80 mg Every Other Week With Methotrexate

NCT01270035 is registered in ClinicalTrials.gov with Keio University as lead sponsor.

NCT NCT01270035
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01270035 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Adalimumab 80 mg Every Other Week With Methotrexate
Lead sponsor
Keio University
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2011
Completion date
Not reported
Enrollment
40 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis